Your browser doesn't support javascript.
loading
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.
Samuels, Brian L; Chawla, Sant P; Somaiah, Neeta; Staddon, Arthur P; Skubitz, Keith M; Milhem, Mohammed M; Kaiser, Pamela E; Portnoy, David C; Priebat, Dennis A; Walker, Mark S; Stepanski, Edward J.
Affiliation
  • Samuels BL; Summit Cancer Centers, Post Falls, Idaho.
  • Chawla SP; Sarcoma Oncology Center, Santa Monica, California.
  • Somaiah N; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Staddon AP; Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Skubitz KM; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Milhem MM; Medical Oncology, University of Iowa, Iowa City, Iowa.
  • Kaiser PE; Oncology Specialists, Park Ridge, Illinois.
  • Portnoy DC; West Cancer Center, Memphis, Tennessee.
  • Priebat DA; Department of Medical Oncology, Medstar Washington Hospital Center, Washington, District of Columbia.
  • Walker MS; Vector Oncology, Memphis, Tennessee.
  • Stepanski EJ; Vector Oncology, Memphis, Tennessee.
Cancer ; 123(23): 4640-4647, 2017 Dec 01.
Article in En | MEDLINE | ID: mdl-28832986

Full text: 1 Collection: 01-internacional Health context: 3_ND / 4_TD Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Angiogenesis Inhibitors / Liposarcoma Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 3_ND / 4_TD Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Angiogenesis Inhibitors / Liposarcoma Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2017 Document type: Article